BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 49 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $62,140,000 | -2.0% | 60,350,000 | +0.6% | 0.02% | 0.0% |
| Q2 2018 | $63,435,000 | +92.8% | 60,000,000 | +86.0% | 0.02% | +12.5% |
| Q1 2018 | $32,897,000 | +33.3% | 32,255,000 | +41.4% | 0.02% | 0.0% |
| Q4 2017 | $24,678,000 | +27.8% | 22,811,000 | +31.8% | 0.02% | +23.1% |
| Q3 2017 | $19,314,000 | +495.9% | 17,313,000 | +491.9% | 0.01% | +550.0% |
| Q2 2017 | $3,241,000 | -45.3% | 2,925,000 | -44.8% | 0.00% | -60.0% |
| Q4 2016 | $5,926,000 | +251.7% | 5,300,000 | +277.2% | 0.01% | +400.0% |
| Q3 2016 | $1,685,000 | -65.4% | 1,405,000 | -68.0% | 0.00% | -66.7% |
| Q2 2016 | $4,875,000 | +61.4% | 4,390,000 | +68.3% | 0.00% | +50.0% |
| Q1 2016 | $3,021,000 | -85.9% | 2,609,000 | -84.4% | 0.00% | -86.7% |
| Q4 2015 | $21,466,000 | +109.0% | 16,722,000 | +110.3% | 0.02% | +87.5% |
| Q3 2015 | $10,272,000 | +39.3% | 7,952,000 | +66.2% | 0.01% | +60.0% |
| Q2 2015 | $7,376,000 | +44.3% | 4,786,000 | +39.4% | 0.01% | +66.7% |
| Q1 2015 | $5,110,000 | +3.4% | 3,434,000 | -18.3% | 0.00% | 0.0% |
| Q4 2014 | $4,943,000 | -9.2% | 4,205,000 | -18.3% | 0.00% | 0.0% |
| Q3 2014 | $5,446,000 | -10.7% | 5,144,000 | -12.7% | 0.00% | -25.0% |
| Q2 2014 | $6,097,000 | +33772.2% | 5,895,000 | +34576.5% | 0.00% | – |
| Q4 2013 | $18,000 | – | 17,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|